A mutation in vesicular acetylcholine transporter increases tubulin acetylation compromising axonal transport
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Kinesin-3 UNC-104(KIF1A) is the major transporter of synaptic vesicles and genetic defects in this motor are linked to Charcot-Marie-Tooth disease and hereditary spastic paraplegia. In a candidate screen for genes causing neurotransmission defects in C. elegans and simultaneously affecting post-translational modification of tubulin, we identified allele unc-17 ( e245 ) significantly elevating tubulin acetylation in neurons. UNC-17 encodes for a VAChT (vesicle acetylcholine transporter) and its human ortholog is implicated in Alzheimer’s disease. Elevated tubulin acetylation compromises motility of UNC-104 as well its cargo RAB-3. Motility of UNC-104 improves when knocking down alpha-tubulin acetyltransferase MEC-17(ATAT1) in unc-17 ( e245 ) strains. Conversely, motility of UNC-104 is negatively affected when overexpressing MEC-17 in wild type animals. Critically, transport defects are comparable when exposing nematodes to drugs that inhibit ACh neurotrans-mission. Both UNC-104 and UNC-17 as well as UNC-104 and MEC-17 colocalize in neurons and bimolecular fluorescence complementation assays (BiFC) reveal physical in situ interactions between UNC-104/UNC-17, UNC-104/MEC-17 and UNC-17/MEC-17. We propose a model in which reduced expression of UNC-17 frees MEC-17 from the UNC-104/UNC-17 complex. This leads to increased tubulin acetylation, which in turn negatively affects UNC-104 motility.